ITRMF Iterum Therapeutics plc
Healthcare · Market cap: not available
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $37.5K |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $22.2K | $238.8K |
| 2022-Q4 | $0 | $4.4K |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $109.9K | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $10.8K | $0 |
| 2025-Q4 | $2.2K | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$145.1K7 buy days
Sold$280.7K11 sell days
Net insider flow-$135.6Knet selling · 5 years
Latest trade2025-11-18Dunne Michael W.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2025-11-18 | Buy | Dunne Michael W. | Director | 6,000 | $0.37 | $2.2K | 1 |
| 2025-08-08 | Buy | Dunne Michael W. | Director | 15,000 | $0.72 | $10.8K | 1 |
| 2023-12-22 | Buy | Dunne Michael W. | Director | 25,000 | $1.40 | $35.0K | 1 |
| 2023-12-18 | Buy | Dunne Michael W. | Director | 10,000 | $1.84 | $18.4K | 1 |
| 2023-11-22 | Buy | Dunne Michael W. | Director | 20,000 | $2.03 | $40.6K | 1 |
| 2023-11-20 | Buy | Fishman Corey N. | CEO | 10,000 | $1.59 | $15.9K | 1 |
| 2022-12-02 | Sell | Puttagunta Sailaja | Other C-suite | 3,365 | $1.32 | $4.4K | 1 |
| 2022-09-20 | Sell | Ahrens Brenton Karl | Director | 7,246 | $1.78 | $12.9K | 1 |
| 2022-09-19 | Sell | Ahrens Brenton Karl | Director | 15,000 | $1.77 | $26.6K | 1 |
| 2022-09-16 | Sell | Ahrens Brenton Karl | Director | 15,000 | $1.90 | $28.5K | 1 |
| 2022-09-15 | Sell | Ahrens Brenton Karl | Director | 15,000 | $2.02 | $30.3K | 1 |
| 2022-09-14 | Sell | Ahrens Brenton Karl | Director | 15,000 | $2.10 | $31.5K | 1 |
| 2022-09-13 | Sell | Ahrens Brenton Karl | Director | 15,000 | $2.14 | $32.1K | 1 |
| 2022-09-12 | Sell | Ahrens Brenton Karl | Director | 15,000 | $2.31 | $34.6K | 1 |
| 2022-09-09 | Sell | Ahrens Brenton Karl | Director | 15,000 | $2.32 | $34.8K | 1 |
| 2022-09-08 | Sell | Ahrens Brenton Karl | Director | 3,298 | $2.26 | $7.5K | 1 |
| 2022-09-07 | Buy | Dunne Michael W. | Director | 10,000 | $2.22 | $22.2K | 1 |
| 2022-03-14 | Sell | Matthews Judith M. | CFO | 110,472 | $0.34 | $37.5K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Ahrens Brenton Karl | Director | $0 | $238.8K | 2022-09-20 |
| Dunne Michael W. | Director | $129.2K | $0 | 2025-11-18 |
| Matthews Judith M. | CFO | $0 | $37.5K | 2022-03-14 |
| Fishman Corey N. | CEO | $15.9K | $0 | 2023-11-20 |
| Puttagunta Sailaja | Other C-suite | $0 | $4.4K | 2022-12-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2018-08-17 → 2018-09-04 | 3 | $37.7K | 46 | -32.8% (-34.6% raw) | -23.3% (-34.6% raw) | -38.7% (-47.0% raw) | closed |
| 2018-05-30 | 11 | $56.9M | 66 | -14.7% (-14.6% raw) | -24.3% (-16.7% raw) | -48.2% (-46.4% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.